Cargando…
Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation
While genomic studies have improved our ability to classify sarcomas, the molecular mechanisms involved in the formation and progression of many sarcoma subtypes are unknown. To better understand developmental origins and genetic drivers involved in rhabdomyosarcomagenesis, we describe a novel sarco...
Autores principales: | McKinnon, Timothy, Venier, Rosemarie, Dickson, Brendan C., Kabaroff, Leah, Alkema, Manon, Chen, Li, Shern, Jack F., Yohe, Marielle E., Khan, Javed, Gladdy, Rebecca A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546462/ https://www.ncbi.nlm.nih.gov/pubmed/25992772 |
Ejemplares similares
-
Development of Genetically Flexible Mouse Models of Sarcoma Using RCAS-TVA Mediated Gene Delivery
por: Kabaroff, Leah, et al.
Publicado: (2014) -
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
por: Babichev, Yael, et al.
Publicado: (2016) -
Tetraploidization of Immortalized Myoblasts Induced by Cell Fusion Drives Myogenic Sarcoma Development with DMD Deletion
por: Merle, Candice, et al.
Publicado: (2020) -
Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
por: Tenente, Inês M, et al.
Publicado: (2017) -
ZBED6 Modulates the Transcription of Myogenic Genes in Mouse Myoblast Cells
por: Jiang, Lin, et al.
Publicado: (2014)